Saladax Secures $9M Loan Facility from GE Capital

Saladax will use the money to further commercialize its My5-FU assay, which measures levels of 5-flourouracil, a chemotherapy used for colorectal cancer and other solid tumors.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.